Browse: Departments Dates Agencies
SUBJECT CATEGORY: Pulmonary-Allergy Drug Advisory Committee; Cancellation
DOCUMENT SUMMARY: The meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for February 20, 2008, is cancelled. This meeting was announced in the Federal Register of December 21, 2007 (72 FR 72737).
SUMMARY: Pulmonary-Allergy Drug Advisory Committee; Cancellation,
FOR FURTHER INFORMATION CONTACT Teresa A. Watkins, Center for Drug
Evaluation and Research (HFD21), Food and Drug Administration, 5630
Fishers Lane (for express delivery, rm. 1093), Rockville, MD 20857,
3018277001, FAX: 3018276776, email: Teresa.Watkins@fda.hhs.gov, or
FDA Advisory Committee Information Line, 18007418138 (3014430572
in the Washington, DC area), code 3014512545. Please call the Information Line for uptodate information on this meeting.
Dated: January 29, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E81959 Filed 2108; 8:45 am]
BILLING CODE 416001S
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 50 CFR Part 679 47 CFR Part 73 26 CFR Part 1 40 CFR Part 180 33 CFR Part 117 50 CFR Part 17 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 40 CFR Part 63 33 CFR Part 100 50 CFR Part 622 50 CFR Part 660 26 CFR Part 301 44 CFR Part 65 39 CFR Part 111 40 CFR Part 300 6 CFR Part 5 40 CFR Part 271 47 CFR Part 64 40 CFR Parts 52 and 81 50 CFR Part 665 10 CFR Part 50 44 CFR Part 64 49 CFR Part 571 39 CFR Part 3020